RecruitingNot applicableNCT06830356

Somatostatin Receptor PET Imaging to Guide Radiotherapy Dose Escalation in High Risk Meningiomas.

Studying Meningioma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centro di Riferimento Oncologico - Aviano
Principal Investigator
Lorenzo Vinante
Centro di Riferimento Oncologico di Aviano (CRO)
Intervention
Dose escalation of radiation therapy, based on somatostatin receptor PET imaging(radiation)
Enrollment
53 enrolled
Eligibility
16 years · All sexes
Timeline
2024 – 2037

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06830356 on ClinicalTrials.gov

Other trials for Meningioma

Additional recruiting or active studies for the same condition.

See all trials for Meningioma →

← Back to all trials